January 11, 2016 /PRNewswire/ —
OWC Pharmaceutical Research Corp. (OTC: OWCP), an
Israel-based pharmaceutical research company dedicated to the development of cannabinoid treatments, products and delivery technologies, today announced that it has entered into a
$750,000 equity purchase agreement (“Agreement”) with Kodiak Capital Group, LLC (“Kodiak”).
(Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )
(Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )
ORIGINAL SOURCE: Click Here to Continue Reading Article…